A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background/Aims: The objective of this prospective study was to evaluate the diagnosis and treatment of latent tuberculosis infection (LTBI) in adult close contacts of active pulmonary tuberculosis (TB) patients in Korea. Methods: Adult close contacts of active pulmonary TB patients were recruited at a regional tertiary hospital in Korea. The participants were tested for LTBI using the tuberculin skin test (TST) and/or QuantiFERON-TB Gold (QFT-G) test. LTBI patients, who consented to treatment, were randomly assigned to receive isoniazid for 9 months (9INH) or rifampin for 4 months (4RIF). Results: We examined 189 adult close contacts (> 18 years) of 107 active pulmonary TB patients. The TST and QFT-G were positive (≥ 10 mm) in 75/183 (39.7%) and 45/118 (38.1%) tested participants, respectively. Among 88 TST or QFT-G positive LTBI participants, 45 participants were randomly assigned to receive 4RIF (n = 21) or 9INH (n = 24), respectively. The average treatment duration for the 4RIF and 9INH groups was 3.3 ± 1.3 and 6.1 ± 2.7 months, respectively. Treatment was completed in 25 participants (4RIF, n = 16; 9INH, n = 9). LTBI participants who accepted treatment were more likely to be women and have more cavitary lesions on the chest radiographs of index cases and positive TST and QFT-G results compared to those who refused treatment. Conclusions: About 40% of adult close contacts of active pulmonary TB patients had LTBI; about 50% of these LTBI participants agreed to treatment.
Abstract
Background/Aims: The objective of this prospective study was to evaluate the diagnosis and treatment of latent tuberculosis infection (LTBI) in adult close contacts of active pulmonary tuberculosis (TB) patients in Korea. Methods: Adult close contacts of active pulmonary TB patients were recruited at a regional tertiary hospital in Korea. The participants were tested for LTBI using the tuberculin skin test (TST) and/or QuantiFERON-TB Gold (QFT-G) test. LTBI patients, who consented to treatment, were randomly assigned to receive isoniazid for 9 months (9INH) or rifampin for 4 months (4RIF). Results: We examined 189 adult close contacts (> 18 years) of 107 active pulmonary TB patients. The TST and QFT-G were positive (≥ 10 mm) in 75/183 (39.7%) and 45/118 (38.1%) tested participants, respectively. Among 88 TST or QFT-G positive LTBI participants, 45 participants were randomly assigned to receive 4RIF (n = 21) or 9INH (n = 24), respectively. The average treatment duration for the 4RIF and 9INH groups was 3.3 ± 1.3 and 6.1 ± 2.7 months, respectively. Treatment was completed in 25 participants (4RIF, n = 16; 9INH, n = 9). LTBI participants who accepted treatment were more likely to be women and have more cavitary lesions on the chest radiographs of index cases and positive TST and QFT-G results compared to those who refused treatment. Conclusions: About 40% of adult close contacts of active pulmonary TB patients had LTBI; about 50% of these LTBI participants agreed to treatment.
참고문헌 (24)
- Raviglione MC, "Harrison’s Principles of Internal Medicine", pp.1340~1359 (2012), McGraw-Hill
- Global Tuberculosis Report 2013, "World Health Organization", World Health Organization, ~ (2013)
- 이승준, "일개 병원의 의료인에서 투베르쿨린 검사와 QuantiFERON-TB Gold 검사를 이용한 잠복결핵의 진단과 치료", Tuberculosis and Respiratory Diseases, 62(4), pp.270~275 (2007), 대한결핵및호흡기학회
- Lee K, "Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university hospital", Infect Control Hosp Epidemiol, 30, pp.1218~1222 (2009)
- Song S, "Performance of confirmatory interferon-gamma release assays in school TB outbreaks", Chest, 141, pp.983~988 (2012)
- 박재석, "폐결핵환자 접촉자에서 결핵감염의 빈도와 결핵감염의 위험인자", Tuberculosis and Respiratory Diseases, 72(2), pp.140~148 (2012), 대한결핵및호흡기학회
- National Center for HIV, "AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination", Latent Tuberculosis Infection: A Guide for Primary Health Care Providers, 2010
- Horsburgh CR Jr, "Priorities for the treatment of latent tuberculosis infection in the United States", N Engl J Med, 350, pp.2060~2067 (2004)
- 이승헌, "Diagnosis and Treatment of Latent Tuberculosis Infection", Tuberculosis and Respiratory Diseases, 78(2), pp.56~63 (2015), 대한결핵및호흡기학회
- Sokal JE, "Editorial: measurement of delayed skin-test responses", N Engl J Med, 293, pp.501~502 (1975)
- Choi JC, "The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection", Chest, 133, pp.1415~1420 (2008)
- Brock I, "Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts", Am J Respir Crit Care Med, 170, pp.65~69 (2004)
- Mori T, "Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens", Am J Respir Crit Care Med, 170, pp.59~64 (2004)
- Kang YA, "Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country", JAMA, 293, pp.2756~2761 (2005)
- Morrison J, "Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis", Lancet Infect Dis, 8, pp.359~368 (2008)
- Jo KW, "Poor correlation between tuberculin skin tests and interferon-gamma assays in close contacts of patients with multidrug-resistant tuberculosis", Respirology, 17, pp.1125~1130 (2012)
- Diel R, "Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis", Chest, 135, pp.1010~1018 (2009)
- Shanaube K, "Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa", PLoS One, 6, pp.e18206~ (2011)
- Arend SM, "Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts", Am J Respir Crit Care Med, 175, pp.618~627 (2007)
- Adetifa IM, "Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia", BMC Infect Dis, 7, pp.122~ (2007)
- de Souza-Galvao ML, "Correlation between tuberculin skin test and IGRAs with risk factors for the spread of infection in close contacts with sputum smear positive in pulmonary tuberculosis", BMC Infect Dis, 14, pp.258~ (2014)
- Lee SJ, "Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea: a prospective cohort study", BMC Infect Dis, 14, pp.566~ (2014)
- Smith BM, "Treatment of latent TB: first do no harm", Expert Rev Anti Infect Ther, 9, pp.491~493 (2011)
- Goswami ND, "Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study", BMC Public Health, 12, pp.468~ (2012)